News & Media

Egypt combats hepatitis C epidemic with state-run scheme

09 Feb 2017

https://www.ft.com/content/d1e18e96-d81b-11e6-944b-e7eb37a6aa8e

World Hepatitis Day in Egypt focuses on hepatitis B and C prevention

09 Feb 2017

Cairo, 23 July, 2015 – The WHO Regional Office for the Eastern Mediterranean will host an event to observe World Hepatitis Day on 28 July 2015 in Cairo, Egypt. The regional theme of this year’s day is “Prevent hepatitis B and C”. It aims to generate both political and public awareness and action around the need to prevent hepatitis B and C.

Viral hepatitis is a global health problem affecting hundreds of millions of people worldwide. An estimated 1.45 million people die annually from all types of viral hepatitis, mostly from liver disease and cancer caused by these infections. Every day, thousands of people are newly infected because they lack access to information and services for prevention and treatment. Many of these people are unaware of their infection until diagnosed and have the potential to transmit the viruses to others. This year, WHO and its partners are urging policy-makers, health workers and the public to take action to prevent infection and death from hepatitis.  

http://www.emro.who.int/media/news/world-hepatitis-day-in-egypt-focuses-on-hepatitis-b-and-c-prevention.html

Hepatitis C treatment for under $300 coming soon

Hepatitis C treatment for under $300 coming soon

09 Feb 2017

It's about time...$80,000 for a 12 week course of Hep C medication is just ridiculous! I'm glad that they are working on options that are affordable and bring effective treatments to the people that need them most.

Alves dona 1.000 tratamientos para curar la hepatitis C | Liga BBVA | AS.com

Alves dona 1.000 tratamientos para curar la hepatitis C | Liga BBVA | AS.com

27 Jan 2017

Alves dona 1.000 tratamientos para curar la hepatitis C | Liga BBVA | AS.com

futbol.as.com

Barcelona: Alves dona 1.000 tratamientos para curar la hepatitis C

Dani Alves: ‘What FC Barcelona has achieved is huge’ | FC Barcelona

Dani Alves: ‘What FC Barcelona has achieved is huge’ | FC Barcelona

25 Jan 2017

www.fcbarcelona.com

The Brazilian is also confident that his team are going to carry on delivering more success to their supporters

Messi in Egypt to plug Tour n’ Cure

16 Nov 2016

Barcelona FC star Lionel Messi will be in Egypt to promote the Tour n’ Cure hepatitis C medical tourism program, which has the endorsement of the Catalan club, said Civil Aviation Minister Sherif Fathy.

http://enterprise.press/stories/2016/11/16/messi-in-egypt-to-plug-tour-n-cure/

 

HCV treatment in Egypt, Why cost remains a challenge ?

01 Nov 2016

Egypt has the highest prevalence rate of hepatitis C virus (HCV) in the world, making it the most challenging
public health problem facing the country. Studies show that 14.7% of the Egyptian population carry HCV antibodies1
and 9.8% have an active infection.

http://www.eipr.org/sites/default/files/pressreleases/pdf/
hcv_treatment_in_egypt.pdf

Hepatitis C cure for under $300 US fuels excitement

15 Apr 2016

A combination hepatitis C cure that is so costly it's rationed in Canada will be available in middle-income countries for less than $300 US, a move that opens the window to more affordable treatment in this country, a physician with Doctors Without Borders says.

There are an estimated 301,000 cases of Hepatitis C cases in Canada. The silent killer often doesn't cause symptoms until the liver is severely damaged. Chronic infection can cause inflammation of the liver, scarring of the organ, cirrhosis and other complications, including liver cancer.

http://www.cbc.ca/news/health/hepatitis-c-1.3538623

Una ONG impulsa tratamientos contra la hepatitis C de menos de 300 euros

13 Apr 2016

La mayoría de los afectados por la enfermedad vive en los países más pobres, donde los precios actuales son imposibles de asumir

Drugs for Neglected Diseases initiative and Pharco Pharmaceuticals to test affordable hepatitis C regimen with support of Malaysian and Thai governments

13 Apr 2016

The Drugs for Neglected Diseases initiative (DNDi) and the Egyptian drug manufacturer Pharco Pharmaceuticals have signed agreements covering the clinical testing and scale-up of a hepatitis C treatment regimen at a price of just under $300.

http://www.dndi.org/2016/media-centre/press-releases/dndi-pharco-hepc-malaysia-thailand/

MESSI SIGNS WITH EGYPTIAN PROGRAM TOUR N’ CURE

MESSI SIGNS WITH EGYPTIAN PROGRAM TOUR N’ CURE

09 Feb 2017

It’s not everyday that the number one soccer player in the world gets signed as an ambassador of an enterprise—let alone an Egyptian one—but when the initiative is for that big of a cause, he couldn’t decline the offer! Joining Dani Alvis, Lionel Messi is now officially the face of Tour n’ Cure.

http://seethrumag.com/messi-signs-with-egyptian-program-tour-n-cure/

Pharco Pharmaceuticals Reports Ravidasvir Achieved 100% Cure Rate To Date When Combined With Sofosbuvir For HCV, Non-Cirrhotic, Genotype 4 Patients

09 Feb 2017

ALEXANDRIA, Egypt--(BUSINESS WIRE)--Egypt’s leading drug manufacturer Pharco Pharmaceuticals, Inc. announced advanced results today from its Phase III clinical trial of the combination of ravidasvir with sofosbuvir for the treatment of patients with genotype-4 chronic hepatitis C virus, the largest study of its kind globally

http://www.biospace.com/news_story.aspx?StoryID=399790&full=1

Lionel Messi empapela El Cairo como rostro contra la Hepatitis C

Lionel Messi empapela El Cairo como rostro contra la Hepatitis C

31 Jan 2017

Desde hace días Lionel Messi es un personaje ubicuo sobre el asfalto de la megalópolis egipcia por el que desfilan a diario unos veinte millones de almas. Su imagen asoma en los gigantescos reclamos que habitan las principales y caóticas arterias de El Cairo. El futbolista argentino se ha convertido en el rostro de un programa que ofrece tratamiento contra la Hepatitis C a egipcios y foráneos en un país que lidera la clasificación mundial de enfermos del virus.

http://www.elmundo.es/loc/2017/01/31/5890cd1fe5fdea691a8b45ae.html

Dani Alves financiará mil tratamientos contra la hepatitis C

Dani Alves financiará mil tratamientos contra la hepatitis C

27 Jan 2017

www.sport.es

El brasileño presenta su acuerdo con la farmacéutica egipcia Pharco para convetirse en embajador mundial contra la hepatitis C

Egypt hosts World Hepatitis Day 2015

01 Dec 2016

WHO celebrated World Hepatitis Day 2015 in Cairo in recognition of Egypt’s ‎pioneering role in combatting viral hepatitis. Egypt is supporting a comprehensive approach for tackling hepatitis through their “Plan of action for the prevention, care and treatment of viral hepatitis 2014–2018". Led by the National Committee of Control for Viral Hepatitis, Egypt has spearheaded the treatment of hepatitis C with the new drug Sofosbuvir which has been shown to cure more than 90% of patients. Egypt has plans to treat 150 000 patients by the end of 2015, and another 300 000 by the end of 2016.

http://www.emro.who.int/egy/egypt-news/world-hepatitis-day-2015.html

Pharco Pharmaceuticals Inc. Reports Ravidasvir Achieved 100% Cure Rate to Date When Combined with Sofosbuvir for HCV, Non-Cirrhotic, Genotype 4 Patients

16 Nov 2016

ALEXANDRIA, Egypt--(BUSINESS WIRE)--Egypt’s leading drug manufacturer Pharco Pharmaceuticals, Inc. announced advanced results today from its Phase III clinical trial of the combination of ravidasvir with sofosbuvir for the treatment of patients with genotype-4 chronic hepatitis C virus, the largest study of its kind globally.

“This study suggests that we don’t need ribavirin when using ravidasvir and sofosbuvir for genotype 4 non-cirrhotics, even if the patient previously failed on Interferon.”

http://www.businesswire.com/news/home/20151116005444/en/Pharco-Pharmaceuticals-Reports-Ravidasvir-Achieved-100-Cure

$300 vs. $80,000: Low-cost cure for hepatitis C in the works

$300 vs. $80,000: Low-cost cure for hepatitis C in the works

18 Apr 2016

A non-profit group is working to develop an affordable treatment for hepatitis C that will cost less than US$300 per patient – a tiny fraction of the $80,000 price tag currently charged by big drug makers to treat the liver infection.

http://www.ctvnews.ca/health/300-vs-80-000-low-cost-cure-for-hepatitis-c-in-the-works-1.2863890

Hepatitis C treatment for under $300 coming soon

Hepatitis C treatment for under $300 coming soon

13 Apr 2016

 

Drugs for Neglected Diseases initiative says drug successfully tested in Egypt could be available within 18-24 months

http://bit.ly/2kCBDrZ
A hepatitis C treatment that costs less than $300 (£210) – a tiny fraction of the $80,000-plus price charged by major drugmakers – has been successfully tested in Egypt and is expected to be available within two years.

$300 hepatitis C combination to enter clinical trials

13 Apr 2016

The Drugs for Neglected Diseases Initiative (DNDI) is launching clinical trials in Thailand and Malaysia to test a combination of sofosbuvir and ravidasvir, an NS5A inhibitor, in at least 800 people with all genotypes of hepatitis C virus (HCV). The combination, manufactured by Egyptian company Pharco, could be made available for US$300 for a course of treatment if it proves safe and effective, DNDI executive director Bernard Pécoul announced ahead of the 2016 International Liver Congress in Barcelona on Wednesday.

http://www.infohep.org/300-hepatitis-C-combination-to-enter-clinical-trials/page/3050022/

Curing Hepatitis C, in an Experiment the Size of Egypt

09 Dec 2015

A new approach tested in Egypt could become the blueprint for providing cutting-edge medicines to the poor.

https://www.nytimes.com/2015/12/16/health/hepatitis-c-treatment-egypt.html?_r=2